CCF Research Grant Program

Funding Agency:
Childrens Cardiomyopathy Foundation

The Children's Cardiomyopathy Foundation (CCF) is committed to improving outcomes and quality of life for children with all forms of cardiomyopathy. CCF’s research grant program aims to advance medical knowledge on the causes and mechanism of pediatric cardiomyopathy and to develop diagnostic guidelines and targeted therapies.

CCF offers funding for basic science, clinical, population/epidemiologic and translational research on cardiomyopathies affecting children aged 18 years and younger. This includes support for studies focused on the causes, evaluation or treatment of dilated, hypertrophic, restrictive, arrhythmogenic right ventricular and left ventricular non-compaction cardiomyopathy as it relates to the pediatric population.

CCF's grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding by the National Institutes of Health and other major granting institutions.

Deadline for Letter of Intent: June 13, 2018

Agency Website

Eligibility Requirements

Principal investigator must hold an M.D., Ph.D. or equivalent degree and reside in the United States or Canada. The investigator must have a faculty appointment at an accredited U.S. or Canadian medical institution and have the ability to conduct independent research with publications in established peer-reviewed medical and scientific journals.



Amount Description

Funding is available in the range of US$25,000 to US$50,000 for one year of total direct costs. Following the completion of the proposed study, a second year of funding may be requested by application. Upon receipt of a signed CCF letter of agreement and IRB or IACUC approval, CCF will disburse funds in installments during the grant period.

Funding Type



Junior Faculty


Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

June 13, 2018